APA (7th ed.) Citation

Itakura, G., Kobayashi, Y., Nishimura, S., Iwai, H., Takano, M., Iwanami, A., . . . Nakamura, M. Controlling immune rejection is a fail-safe system against potential tumorigenicity after human iPSC-derived neural stem cell transplantation. Public Library of Science (PLoS).

Chicago Style (17th ed.) Citation

Itakura, Go, Yoshiomi Kobayashi, Soraya Nishimura, Hiroki Iwai, Morito Takano, Akio Iwanami, Yoshiaki Toyama, Hideyuki Okano, and Masaya Nakamura. Controlling Immune Rejection Is a Fail-safe System Against Potential Tumorigenicity After Human IPSC-derived Neural Stem Cell Transplantation. Public Library of Science (PLoS).

MLA (9th ed.) Citation

Itakura, Go, et al. Controlling Immune Rejection Is a Fail-safe System Against Potential Tumorigenicity After Human IPSC-derived Neural Stem Cell Transplantation. Public Library of Science (PLoS).